日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteria

阿普拉霉素治疗非结核分枝杆菌的多中心临床前研究

Nguyen, Minh-Vu H; Plattner, Michel; Verma, Deepshikha; Krishnamurthy, Ramya V; Xie, Min; Calado Nogueira de Moura, Vinicius; Haldimann, Klara; Lang, Ramon; Becker, Katja; Kaur, Parvinder; Shandil, Radha Krishan; Singh, Mayas; Bulman, Zackery P; Dick, Thomas; Narayanan, Shridhar; Schulthess, Bettina; Mitarai, Satoshi; Daley, Charles L; Hobbie, Sven N

Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library.

高三尖杉酯碱在体外抑制 CVS-11 和狂犬病毒临床分离株:通过对 FDA 批准的药物库进行高通量筛选而发现

Harisha Kalenahalli Rajappa, Kailaje Varun, Kondreddi Ravinder Reddy, Gudla Chandra Sekhar, Singh Shraddha, Ramakrishnaiah Sharada, Isloor Shrikrishna, Narayanan Shridhar, Shandil Radha Krishan, Rudramurthy Gudepalya Renukaiah

A Novel Inhibitor against the Biofilms of Non-Tuberculous Mycobacteria

一种新型的非结核分枝杆菌生物膜抑制剂

Kaur, Parvinder; Krishnamurthy, Ramya Vadageri; Shandil, Radha Krishan; Mohan, Rahul; Narayanan, Shridhar

Novel Baicalein-Derived Inhibitors of Plasmodium falciparum

新型黄芩苷衍生的恶性疟原虫抑制剂

Gudla, Chandra Sekhar; Selvam, Vignesh; Selvaraj, Siva Shanmugam; Tripathi, Renu; Joshi, Prince; Shaham, Salique Hassan; Singh, Mayas; Shandil, Radha Krishan; Habib, Saman; Narayanan, Shridhar

Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases

间充质干细胞(MSCs)在自身免疫性疾病临床前模型中的治疗潜力评价

Shandil, Radha Krishan; Dhup, Saumya; Narayanan, Shridhar

Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense

透过反义寡核苷酸揭示分枝杆菌杀灭作用的秘密

Kaur, Parvinder; Datta, Santanu; Shandil, Radha Krishan; Kumar, Naveen; Robert, Nanduri; Sokhi, Upneet K; Guptha, Supreeth; Narayanan, Shridhar; Anbarasu, Anand; Ramaiah, Sudha